Casey Hoerth
Long only, long-term horizon, growth at reasonable price, dividend investing

What Core Labs Tells Us About The 'Second Wave' Shale Plays

Core Laboratories (NYSE: CLB), a mid-cap oil servicer focusing on production enhancement and research optimization, has recently been savaged since giving lower revenue and earnings guidance. Core lowered full-year earnings guidance from $6.00-$6.25 to $5.80-$6.00 per share. Revenue for the second quarter is now estimated to be between $265 and $270 million; a number less than the previous estimate, but still above last year's second quarter results. The analysts estimated revenue to be around $288 million.

The reaction was pretty brutal, with the stock declining by as much as 20% on the day of the announcement, partly because this was a genuine downward revision on the part of management, but also because consensus expectations got too optimistic.


Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details